OOIR: Observatory of International Research

Papers

(The median citation count of Current HIV/AIDS Reports is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Adventures in COVID-19 Policy Modeling: Education Edition	72
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory	56
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response	53
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review	44
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries	38
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review	35
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?	32
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review	31
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings	29
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic	28
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?	27
Interventions to Improve Adolescent HIV Care Outcomes	27
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States	27
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure	27
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 2020	25
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa	24
Risk Compensation in Voluntary Medical Male Circumcision Programs	24
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review	22
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t	22
Current Status of HIV-Stigma Reduction Interventions: A Need to Address the Root Causes at Multiple Levels	22
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults	21
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview	20
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice	20
Future of bNAbs in HIV Treatment	20
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy	20

Transition to Adult Care for Young People Living with HIV	19
A Review of Serious Gaming as an Intervention for HIV Prevention	19
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program	19
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence	17
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV	16
VMMC Programmatic Successes and Challenges: Western Kenya Case Study	16
Update on Vaccination Recommendations for Adults with HIV	15
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?	15
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa	15
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy	15
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era	14
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review	14
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions	14
Fatty Liver Disease: Enter the Metabolic Era	14
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups	14
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research	14
Mpox and HIV: a Narrative Review	13
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa	13
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead	13
Advances in HIV Research Using Mass Cytometry	12
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions	12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies	12
Challenges of HIV Management in an Aging Population	11
Correction to: Peer-Led Adjunctive Interventions for Increasing the Reach of HIV Prevention and Care Interventions to Latino/x/e Men Who Have Sex with Men: a Scoping Review	11
Voluntary Medical Male Circumcision to Reduce HIV Acquisition and Transmission	11
Strategies for Hepatitis B Virus Prevention in People Living with HIV	11
Implementation Science for HIV Prevention and Treatment in Indigenous Communities: a Systematic Review and Commentary	10
Reporting Individual-Level Research Results from Neurocognitive and Psychological Research in People Living with HIV: Lessons from Dementia Research	10
Updates on HIV and Kidney Disease	9
Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review	8
The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission	8
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places	8
A Perspective on Home-Based Sexual Health Care: Evidence, Access, and Future Directions	8
Improving Communication: A Narrative Synthesis of Interventions for HIV Disclosure to Pediatric Populations	8
A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era	7
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update	7
Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure	7
Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV	7
Addressing HIV and Substance Use Health Disparities among Racial/Ethnic Minority Individuals	7
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV	7
The New Era of Long-Acting Antiretroviral Therapy: When and Why to Make the Switch	7
Integrated Care Models: HIV and Substance Use	7
Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission	7
Correction to: A Review of Interventions to Enhance HIV Medication Adherence	7
HIV and Pregnancy: Navigating Complex Decision Making and Preventing Perinatal Transmission	6
Social Determinants of Disease: HIV and COVID-19 Experiences	6
Challenges and Solutions to STI Control in the Era of HIV and STI Prophylaxis	6
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines	6
Peer-Led Adjunctive Interventions for Increasing the Reach of HIV Prevention and Care Interventions to Latino/x/e Men Who Have Sex with Men: a Scoping Review	6
HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?	6

Transgender Individuals and Digital Health	6
Peer Approaches to Improve HIV Care Cascade Outcomes: a Scoping Review Focused on Peer Behavioral Mechanisms	6
Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men?	6
COVID-19 Outcomes and Risk Factors Among People Living with HIV	6
CNS Considerations in ART Simplification Strategies	6
Point-of-Care Syphilis Testing: Implementation and Future Direction	5
How Does Voluntary Medical Male Circumcision Reduce HIV Risk?	5
Sustaining HIV Research in Resource-Limited Settings Using PLAN (People, Learning, Adapting, Nurturing): Evidence from the 4 Youth by Youth Project in Nigeria	5
Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV	5
Implementation of Trauma-Informed Care into Clinical HIV Prevention and Care Settings: A Decade of Limited Progress	5
Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review	5
The Role of p53 in HIV Infection	5
Policies and Practices Facilitating Access to and Uptake of HIV Testing Services among Adolescents in Sub-Sahara Africa: A Narrative Review	5
Paradata: Measuring Engagement in Digital HIV Interventions for Sexual and Gender Minorities	4
Antimicrobial Resistance in Curable Sexually Transmitted Infections	4
Implementation Strategies for Digital HIV Prevention and Care Interventions for Youth: A Scoping Review	4
Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome	4
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men	4
Metabolic Complications Associated with Use of Integrase Strand Transfer Inhibitors (InSTI) for the Treatment of HIV-1 Infection: Focus on Weight Changes, Lipids, Glucose and Bone Metabolism	4